APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal Health Surgery Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Animal Health Surgery Drug Market Analysis and Forecast 2026-2032

1 January 2026190 pages

Choose your research edition.

Industry ResearchAnimal Health Surgery Drug Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Health Surgery Drug Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Animal Health Surgery Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Health Surgery Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Health Surgery Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Animal Health Surgery Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Animal Health Surgery Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Animal Health Surgery Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Animal Health Surgery Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Animal Health Surgery Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Animal Health Surgery Drug include Biogenesis Bago SA, Boehringer Ingelheim International GmbH., Ceva Santé Animale, Elanco Animal Health Incorporated, Merck Animal Health (Merck & Co., Inc.), NEOGEN Corporation., Piramal Group, Vetoquinol S.A. and Virbac S.A., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Animal Health Surgery Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Animal Health Surgery Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Animal Health Surgery Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Animal Health Surgery Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Animal Health Surgery Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Animal Health Surgery Drug revenue, projected growth trends, production technology, application and end-user industry.

Animal Health Surgery Drug Segment by Company

Biogenesis Bago SA

Boehringer Ingelheim International GmbH.

Ceva Santé Animale

Elanco Animal Health Incorporated

Merck Animal Health (Merck & Co., Inc.)

NEOGEN Corporation.

Piramal Group

Vetoquinol S.A.

Virbac S.A.

Zoetis

Animal Health Surgery Drug Segment by Type

Anesthetics

Antibiotics

Opioids

Others

Animal Health Surgery Drug Segment by Application

Dental Surgery

Sterilization Surgery

Orthopedic Surgery

Others

Animal Health Surgery Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Health Surgery Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Health Surgery Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Health Surgery Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Animal Health Surgery Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Animal Health Surgery Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Health Surgery Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Animal Health Surgery Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Anesthetics Major Player Table 3. Antibiotics Major Player Table 4. Opioids Major Player Table 5. Others Major Player Table 6. Global Animal Health Surgery Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Dental Surgery Major Player Table 8. Sterilization Surgery Major Player Table 9. Orthopedic Surgery Major Player Table 10. Others Major Player Table 11. Animal Health Surgery Drug Industry Trends Table 12. Animal Health Surgery Drug Industry Drivers Table 13. Animal Health Surgery Drug Industry Opportunities and Challenges Table 14. Animal Health Surgery Drug Industry Restraints Table 15. Global Animal Health Surgery Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Animal Health Surgery Drug Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Animal Health Surgery Drug Market Share by Region (2021-2026) Table 18. Global Animal Health Surgery Drug Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Animal Health Surgery Drug Market Share by Region (2027-2032) Table 20. Global Animal Health Surgery Drug Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Animal Health Surgery Drug Revenue Market Share by Players (2021-2026) Table 22. Global Animal Health Surgery Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Animal Health Surgery Drug Key Players Headquarters & Area Served Table 24. Global Animal Health Surgery Drug Players, Product Type & Application Table 25. Global Animal Health Surgery Drug Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Animal Health Surgery Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Animal Health Surgery Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Animal Health Surgery Drug Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Animal Health Surgery Drug Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Animal Health Surgery Drug Revenue Market Share by Type (2021-2026) Table 32. Global Animal Health Surgery Drug Revenue Market Share by Type (2027-2032) Table 33. Global Animal Health Surgery Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Animal Health Surgery Drug Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Animal Health Surgery Drug Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Animal Health Surgery Drug Revenue Market Share by Application (2021-2026) Table 37. Global Animal Health Surgery Drug Revenue Market Share by Application (2027-2032) Table 38. Biogenesis Bago SA Company Information Table 39. Biogenesis Bago SA Business Overview Table 40. Biogenesis Bago SA Animal Health Surgery Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Biogenesis Bago SA Animal Health Surgery Drug Product Portfolio Table 42. Biogenesis Bago SA Recent Development Table 43. Boehringer Ingelheim International GmbH. Company Information Table 44. Boehringer Ingelheim International GmbH. Business Overview Table 45. Boehringer Ingelheim International GmbH. Animal Health Surgery Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Boehringer Ingelheim International GmbH. Animal Health Surgery Drug Product Portfolio Table 47. Boehringer Ingelheim International GmbH. Recent Development Table 48. Ceva Santé Animale Company Information Table 49. Ceva Santé Animale Business Overview Table 50. Ceva Santé Animale Animal Health Surgery Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Ceva Santé Animale Animal Health Surgery Drug Product Portfolio Table 52. Ceva Santé Animale Recent Development Table 53. Elanco Animal Health Incorporated Company Information Table 54. Elanco Animal Health Incorporated Business Overview Table 55. Elanco Animal Health Incorporated Animal Health Surgery Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Elanco Animal Health Incorporated Animal Health Surgery Drug Product Portfolio Table 57. Elanco Animal Health Incorporated Recent Development Table 58. Merck Animal Health (Merck & Co., Inc.) Company Information Table 59. Merck Animal Health (Merck & Co., Inc.) Business Overview Table 60. Merck Animal Health (Merck & Co., Inc.) Animal Health Surgery Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Merck Animal Health (Merck & Co., Inc.) Animal Health Surgery Drug Product Portfolio Table 62. Merck Animal Health (Merck & Co., Inc.) Recent Development Table 63. NEOGEN Corporation. Company Information Table 64. NEOGEN Corporation. Business Overview Table 65. NEOGEN Corporation. Animal Health Surgery Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. NEOGEN Corporation. Animal Health Surgery Drug Product Portfolio Table 67. NEOGEN Corporation. Recent Development Table 68. Piramal Group Company Information Table 69. Piramal Group Business Overview Table 70. Piramal Group Animal Health Surgery Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Piramal Group Animal Health Surgery Drug Product Portfolio Table 72. Piramal Group Recent Development Table 73. Vetoquinol S.A. Company Information Table 74. Vetoquinol S.A. Business Overview Table 75. Vetoquinol S.A. Animal Health Surgery Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Vetoquinol S.A. Animal Health Surgery Drug Product Portfolio Table 77. Vetoquinol S.A. Recent Development Table 78. Virbac S.A. Company Information Table 79. Virbac S.A. Business Overview Table 80. Virbac S.A. Animal Health Surgery Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Virbac S.A. Animal Health Surgery Drug Product Portfolio Table 82. Virbac S.A. Recent Development Table 83. Zoetis Company Information Table 84. Zoetis Business Overview Table 85. Zoetis Animal Health Surgery Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Zoetis Animal Health Surgery Drug Product Portfolio Table 87. Zoetis Recent Development Table 88. North America Animal Health Surgery Drug Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Animal Health Surgery Drug Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Animal Health Surgery Drug Revenue by Application (2021-2026) & (US$ Million) Table 91. North America Animal Health Surgery Drug Revenue by Application (2027-2032) & (US$ Million) Table 92. North America Animal Health Surgery Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. North America Animal Health Surgery Drug Revenue by Country (2021-2026) & (US$ Million) Table 94. North America Animal Health Surgery Drug Revenue by Country (US$ Million) & (2027-2032) Table 95. Europe Animal Health Surgery Drug Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Animal Health Surgery Drug Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Animal Health Surgery Drug Revenue by Application (2021-2026) & (US$ Million) Table 98. Europe Animal Health Surgery Drug Revenue by Application (2027-2032) & (US$ Million) Table 99. Europe Animal Health Surgery Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Europe Animal Health Surgery Drug Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe Animal Health Surgery Drug Revenue by Country (US$ Million) & (2027-2032) Table 102. China Animal Health Surgery Drug Revenue by Type (2021-2026) & (US$ Million) Table 103. China Animal Health Surgery Drug Revenue by Type (2027-2032) & (US$ Million) Table 104. China Animal Health Surgery Drug Revenue by Application (2021-2026) & (US$ Million) Table 105. China Animal Health Surgery Drug Revenue by Application (2027-2032) & (US$ Million) Table 106. Asia Animal Health Surgery Drug Revenue by Type (2021-2026) & (US$ Million) Table 107. Asia Animal Health Surgery Drug Revenue by Type (2027-2032) & (US$ Million) Table 108. Asia Animal Health Surgery Drug Revenue by Application (2021-2026) & (US$ Million) Table 109. Asia Animal Health Surgery Drug Revenue by Application (2027-2032) & (US$ Million) Table 110. Asia Animal Health Surgery Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Asia Animal Health Surgery Drug Revenue by Region (US$ Million) & (2021-2026) Table 112. Asia Animal Health Surgery Drug Revenue by Region (US$ Million) & (2027-2032) Table 113. SAMEA Animal Health Surgery Drug Revenue by Type (2021-2026) & (US$ Million) Table 114. SAMEA Animal Health Surgery Drug Revenue by Type (2027-2032) & (US$ Million) Table 115. SAMEA Animal Health Surgery Drug Revenue by Application (2021-2026) & (US$ Million) Table 116. SAMEA Animal Health Surgery Drug Revenue by Application (2027-2032) & (US$ Million) Table 117. SAMEA Animal Health Surgery Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. SAMEA Animal Health Surgery Drug Revenue by Country (2021-2026) & (US$ Million) Table 119. SAMEA Animal Health Surgery Drug Revenue by Country (US$ Million) & (2027-2032) Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Animal Health Surgery Drug Image Figure 2. Global Animal Health Surgery Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Health Surgery Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Anesthetics Image Figure 5. Antibiotics Image Figure 6. Opioids Image Figure 7. Others Image Figure 8. Global Animal Health Surgery Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Animal Health Surgery Drug Market Size Share 2021 VS 2025 VS 2032 Figure 10. Dental Surgery Image Figure 11. Sterilization Surgery Image Figure 12. Orthopedic Surgery Image Figure 13. Others Image Figure 14. Global Animal Health Surgery Drug Market Size (US$ Million) & (2021-2032) Figure 15. Global Animal Health Surgery Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Animal Health Surgery Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Animal Health Surgery Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Animal Health Surgery Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Animal Health Surgery Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Animal Health Surgery Drug Revenue Market Share by Type (2021-2032) Figure 22. Global Animal Health Surgery Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Animal Health Surgery Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Animal Health Surgery Drug Revenue Market Share by Application (2021-2032) Figure 25. North America Animal Health Surgery Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Animal Health Surgery Drug Revenue Share by Type (2021-2032) Figure 27. North America Animal Health Surgery Drug Revenue Share by Application (2021-2032) Figure 28. North America Animal Health Surgery Drug Revenue Share by Country (2021-2032) Figure 29. United States Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Animal Health Surgery Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Animal Health Surgery Drug Revenue Share by Type (2021-2032) Figure 34. Europe Animal Health Surgery Drug Revenue Share by Application (2021-2032) Figure 35. Europe Animal Health Surgery Drug Revenue Share by Country (2021-2032) Figure 36. Germany Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Animal Health Surgery Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Animal Health Surgery Drug Revenue Share by Type (2021-2032) Figure 46. China Animal Health Surgery Drug Revenue Share by Application (2021-2032) Figure 47. Asia Animal Health Surgery Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Animal Health Surgery Drug Revenue Share by Type (2021-2032) Figure 49. Asia Animal Health Surgery Drug Revenue Share by Application (2021-2032) Figure 50. Asia Animal Health Surgery Drug Revenue Share by Region (2021-2032) Figure 51. Japan Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Animal Health Surgery Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Animal Health Surgery Drug Revenue Share by Type (2021-2032) Figure 59. SAMEA Animal Health Surgery Drug Revenue Share by Application (2021-2032) Figure 60. SAMEA Animal Health Surgery Drug Revenue Share by Country (2021-2032) Figure 61. Brazil Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Animal Health Surgery Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Anesthetics
  • Antibiotics
  • Opioids
  • Others
Applications
  • Dental Surgery
  • Sterilization Surgery
  • Orthopedic Surgery
  • Others
Companies covered
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH.
  • Ceva Santé Animale
  • Elanco Animal Health Incorporated
  • Merck Animal Health (Merck & Co., Inc.)
  • NEOGEN Corporation.
  • Piramal Group
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Animal Health Surgery Drug Market by Type
  3. 1.2.1 Global Animal Health Surgery Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Anesthetics
  5. 1.2.3 Antibiotics
  6. 1.2.4 Opioids
  7. 1.2.5 Others
  8. 1.3 Animal Health Surgery Drug Market by Application
  9. 1.3.1 Global Animal Health Surgery Drug Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Dental Surgery
  11. 1.3.3 Sterilization Surgery
  12. 1.3.4 Orthopedic Surgery
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Animal Health Surgery Drug Market Dynamics
  1. 2.1 Animal Health Surgery Drug Industry Trends
  2. 2.2 Animal Health Surgery Drug Industry Drivers
  3. 2.3 Animal Health Surgery Drug Industry Opportunities and Challenges
  4. 2.4 Animal Health Surgery Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Animal Health Surgery Drug Market Perspective (2021-2032)
  2. 3.2 Global Animal Health Surgery Drug Growth Trends by Region
  3. 3.2.1 Global Animal Health Surgery Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Animal Health Surgery Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Animal Health Surgery Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Animal Health Surgery Drug Revenue by Players
  2. 4.1.1 Global Animal Health Surgery Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Animal Health Surgery Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Animal Health Surgery Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Animal Health Surgery Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Animal Health Surgery Drug Key Players Headquarters & Area Served
  7. 4.4 Global Animal Health Surgery Drug Players, Product Type & Application
  8. 4.5 Global Animal Health Surgery Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Animal Health Surgery Drug Market CR5 and HHI
  11. 4.6.3 2025 Animal Health Surgery Drug Tier 1, Tier 2, and Tier 3
5 Animal Health Surgery Drug Market Size by Type
  1. 5.1 Global Animal Health Surgery Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Animal Health Surgery Drug Revenue by Type (2021-2032)
  3. 5.3 Global Animal Health Surgery Drug Revenue Market Share by Type (2021-2032)
6 Animal Health Surgery Drug Market Size by Application
  1. 6.1 Global Animal Health Surgery Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Animal Health Surgery Drug Revenue by Application (2021-2032)
  3. 6.3 Global Animal Health Surgery Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Biogenesis Bago SA
  2. 7.1.1 Biogenesis Bago SA Company Information
  3. 7.1.2 Biogenesis Bago SA Business Overview
  4. 7.1.3 Biogenesis Bago SA Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Biogenesis Bago SA Animal Health Surgery Drug Product Portfolio
  6. 7.1.5 Biogenesis Bago SA Recent Developments
  7. 7.2 Boehringer Ingelheim International GmbH.
  8. 7.2.1 Boehringer Ingelheim International GmbH. Company Information
  9. 7.2.2 Boehringer Ingelheim International GmbH. Business Overview
  10. 7.2.3 Boehringer Ingelheim International GmbH. Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Boehringer Ingelheim International GmbH. Animal Health Surgery Drug Product Portfolio
  12. 7.2.5 Boehringer Ingelheim International GmbH. Recent Developments
  13. 7.3 Ceva Santé Animale
  14. 7.3.1 Ceva Santé Animale Company Information
  15. 7.3.2 Ceva Santé Animale Business Overview
  16. 7.3.3 Ceva Santé Animale Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Ceva Santé Animale Animal Health Surgery Drug Product Portfolio
  18. 7.3.5 Ceva Santé Animale Recent Developments
  19. 7.4 Elanco Animal Health Incorporated
  20. 7.4.1 Elanco Animal Health Incorporated Company Information
  21. 7.4.2 Elanco Animal Health Incorporated Business Overview
  22. 7.4.3 Elanco Animal Health Incorporated Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Elanco Animal Health Incorporated Animal Health Surgery Drug Product Portfolio
  24. 7.4.5 Elanco Animal Health Incorporated Recent Developments
  25. 7.5 Merck Animal Health (Merck & Co., Inc.)
  26. 7.5.1 Merck Animal Health (Merck & Co., Inc.) Company Information
  27. 7.5.2 Merck Animal Health (Merck & Co., Inc.) Business Overview
  28. 7.5.3 Merck Animal Health (Merck & Co., Inc.) Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Merck Animal Health (Merck & Co., Inc.) Animal Health Surgery Drug Product Portfolio
  30. 7.5.5 Merck Animal Health (Merck & Co., Inc.) Recent Developments
  31. 7.6 NEOGEN Corporation.
  32. 7.6.1 NEOGEN Corporation. Company Information
  33. 7.6.2 NEOGEN Corporation. Business Overview
  34. 7.6.3 NEOGEN Corporation. Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 NEOGEN Corporation. Animal Health Surgery Drug Product Portfolio
  36. 7.6.5 NEOGEN Corporation. Recent Developments
  37. 7.7 Piramal Group
  38. 7.7.1 Piramal Group Company Information
  39. 7.7.2 Piramal Group Business Overview
  40. 7.7.3 Piramal Group Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Piramal Group Animal Health Surgery Drug Product Portfolio
  42. 7.7.5 Piramal Group Recent Developments
  43. 7.8 Vetoquinol S.A.
  44. 7.8.1 Vetoquinol S.A. Company Information
  45. 7.8.2 Vetoquinol S.A. Business Overview
  46. 7.8.3 Vetoquinol S.A. Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Vetoquinol S.A. Animal Health Surgery Drug Product Portfolio
  48. 7.8.5 Vetoquinol S.A. Recent Developments
  49. 7.9 Virbac S.A.
  50. 7.9.1 Virbac S.A. Company Information
  51. 7.9.2 Virbac S.A. Business Overview
  52. 7.9.3 Virbac S.A. Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Virbac S.A. Animal Health Surgery Drug Product Portfolio
  54. 7.9.5 Virbac S.A. Recent Developments
  55. 7.10 Zoetis
  56. 7.10.1 Zoetis Company Information
  57. 7.10.2 Zoetis Business Overview
  58. 7.10.3 Zoetis Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Zoetis Animal Health Surgery Drug Product Portfolio
  60. 7.10.5 Zoetis Recent Developments
8 North America
  1. 8.1 North America Animal Health Surgery Drug Revenue (2021-2032)
  2. 8.2 North America Animal Health Surgery Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Animal Health Surgery Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Animal Health Surgery Drug Revenue by Type (2027-2032)
  5. 8.3 North America Animal Health Surgery Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Animal Health Surgery Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Animal Health Surgery Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Animal Health Surgery Drug Revenue by Application (2027-2032)
  9. 8.5 North America Animal Health Surgery Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Animal Health Surgery Drug Revenue by Country
  11. 8.6.1 North America Animal Health Surgery Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Animal Health Surgery Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Animal Health Surgery Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Animal Health Surgery Drug Revenue (2021-2032)
  2. 9.2 Europe Animal Health Surgery Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Animal Health Surgery Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Animal Health Surgery Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Animal Health Surgery Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Animal Health Surgery Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Animal Health Surgery Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Animal Health Surgery Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Animal Health Surgery Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Animal Health Surgery Drug Revenue by Country
  11. 9.6.1 Europe Animal Health Surgery Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Animal Health Surgery Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Animal Health Surgery Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Animal Health Surgery Drug Revenue (2021-2032)
  2. 10.2 China Animal Health Surgery Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Animal Health Surgery Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Animal Health Surgery Drug Revenue by Type (2027-2032)
  5. 10.3 China Animal Health Surgery Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Animal Health Surgery Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Animal Health Surgery Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Animal Health Surgery Drug Revenue by Application (2027-2032)
  9. 10.5 China Animal Health Surgery Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Animal Health Surgery Drug Revenue (2021-2032)
  2. 11.2 Asia Animal Health Surgery Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Animal Health Surgery Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Animal Health Surgery Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Animal Health Surgery Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Animal Health Surgery Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Animal Health Surgery Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Animal Health Surgery Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Animal Health Surgery Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Animal Health Surgery Drug Revenue by Country
  11. 11.6.1 Asia Animal Health Surgery Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Animal Health Surgery Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Animal Health Surgery Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Animal Health Surgery Drug Revenue (2021-2032)
  2. 12.2 SAMEA Animal Health Surgery Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Animal Health Surgery Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Animal Health Surgery Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Animal Health Surgery Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Animal Health Surgery Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Animal Health Surgery Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Animal Health Surgery Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Animal Health Surgery Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Animal Health Surgery Drug Revenue by Country
  11. 12.6.1 SAMEA Animal Health Surgery Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Animal Health Surgery Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Animal Health Surgery Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst